Consistent with our findings, a previous functional screening study found that IL-6, IL-1 and GM-CSF signaling were jointly upregulated in a subset of adult AML patients with diverse genomic and disease subtypes62. This evidence concerns the gene IL6 and acute myeloid leukemia.